Lifespan: Why We Age-and Why We Don't Have To A New York Times & International Bestseller "Brilliant and enthralling." Wall Street Journal In this groundbreaking book, Professor Sinclair takes the reader to the frontlines of aging research and reveals incredible breakthroughsmany from his own labthat demonstrate how we can slow down, or even reverse, aging
ETC: electron transfer chain
No Human Efficacy Data Exists As of 2026, no completed randomized controlled trials in humans have been published
Dual anticancer role of metformin: an old drug regulating AMPK dependent/independent pathways in metabolic, oncogenic/tumorsuppresing and immunity context
In the multicenter PIVENS ( PI oglitazone versus V itamin E versus placebo for the treatment of N onalcoholic S teatohepatitis) trial, 247 subjects with MASH but not diabetes mellitus were randomized to receive 30 mg/day of pioglitazone (an insulin-sensitizing drug), 800 IU/day (536 mg/day) of RRR --tocopherol, or a placebo for 96 weeks (97)